News

Read the latest news about issues affecting the neuromuscular disease community.

Blog Post

MDA Welcomes Dr. Don Wood as its New President and CEO

By Nancy Intrator | February 16, 2021
Blog Post

MDA’s 2021 Advocacy Plan

By Mark Fisher | February 2, 2021
Blog Post

Scholar Rock Announces Positive Results from Interim Analysis of TOPAZ Phase 2 Study of SRK-015 to Treat SMA

By Sujatha Gurunathan | October 28, 2020
Blog Post

Amylyx Announces More Results from Study of AMX0035 to Treat ALS

By Sujatha Gurunathan | October 19, 2020
Blog Post

MDA Announces New Collaboration Grants Program for Advocacy Organizations and Partners

By Brittany Hernandez | October 14, 2020
Blog Post

FDA Approves NS Pharma’s Viltepso for Treatment of DMD Amenable to Exon 53 Skipping

By MDA Staff | August 12, 2020
Blog Post

FDA Approves Genentech’s Evrysdi for Treatment of SMA in Pediatric and Adult Patients

By MDA Staff | August 7, 2020
Blog Post

Biogen Announces Positive Results from Phase 1/2 Study of Tofersen to Treat a Genetic Form of ALS

By Sujatha Gurunathan | July 14, 2020
Blog Post

How MDA is Supporting LGMD Research and Care in 2020

By MDA Staff | July 10, 2020
Dr. Stephan Züchner
Blog Post

Five Questions With CMT Researcher Stephan Züchner

By MDA Staff | June 12, 2020